Related by context. All words. (Click for frequent words.) 78 histologic subtype 77 urothelial carcinoma 77 tumor histology 75 HER2 expression 74 pancreatic adenocarcinoma 74 metaplasia 74 lymphoproliferative disorders 73 papillary renal cell carcinoma 73 prostate carcinoma 73 prostate cancer CaP 72 Papillary 72 epithelial tumors 72 Hurthle cell 72 malignant neoplasm 72 mucinous 72 hematopoietic cancers 72 gastric adenocarcinoma 72 colorectal adenoma 72 nodal metastasis 72 neoplasias 72 baseline LDH 72 nonmetastatic 72 Leukemias 72 preoperative PSA 71 clinicopathological features 71 hormone receptor status 71 node metastases 71 Leydig cell 71 locoregional 71 renal cell carcinomas 71 oral squamous cell 71 Squamous 71 breast carcinomas 71 GISTs 71 leiomyomas 71 CIN2 + 71 urothelial cancer 71 pT3 71 endometrial hyperplasia 71 paragangliomas 70 colorectal adenocarcinoma 70 haematologic 70 liver metastasis 70 lymph node metastasis 70 distant metastasis 70 HNSCC 70 ovarian carcinoma 70 clinicopathologic 70 pretransplant 70 prognostic indicators 70 clinico pathological 70 cytologic 70 hepatocellular carcinomas 70 NMIBC 70 seminomas 70 carcinoid tumors 70 tumoral 70 ABCB1 69 gastric cardia 69 invasive ductal 69 ASCUS 69 endocervical 69 basal cell carcinoma BCC 69 breast carcinoma 69 primary hyperparathyroidism 69 surgically resected 69 relapsed MM 69 cranial irradiation 69 MGUS 69 endometrioid 69 osteosarcomas 69 renal cysts 69 gastric carcinoma 69 prognostic variables 69 lung adenocarcinomas 69 invasive carcinoma 69 LHRH receptor positive 69 metastatic lymph nodes 69 operable breast cancer 69 cervical carcinoma 69 Sjögren syndrome 69 progesterone receptor negative 69 K ras mutations 69 nonmelanoma skin cancers 69 squamous cell lung cancer 69 metastatic malignant 69 squamous cell carcinoma SCC 69 essential thrombocythemia 69 microsatellite instability 69 extramedullary 69 sarcomatoid 69 clinicopathological 69 carotid stenosis 69 tumorigenicity 69 PCa 69 Histologic 69 pulmonary metastases 69 HER2 overexpression 69 intraepithelial neoplasia 69 multivariable analysis 69 renal carcinoma 69 neutropaenia 68 coronary stenosis 68 multivariate analyzes 68 T1c 68 metastatic neuroendocrine tumors 68 bronchoalveolar lavage BAL 68 precursor lesions 68 thyroid carcinoma 68 cisplatin resistant 68 completely resected 68 urothelial 68 supratentorial 68 SSc 68 bronchogenic carcinoma 68 monoclonal gammopathy 68 pituitary adenomas 68 multivariate Cox 68 pT2 68 histological diagnosis 68 grade cervical intraepithelial 68 Histological 68 cervical lymph nodes 68 acute myeloid 68 HIV HCV coinfected 68 SUVmax 68 castrate resistant 68 histologic subtypes 68 antiphospholipid antibodies 68 p = #.# [003] 68 orchitis 68 myeloproliferative diseases 68 Postoperative complications 68 FDG uptake 68 testicular tumors 68 hepatorenal syndrome 68 hamartomas 68 HepG2 cells 68 grade squamous intraepithelial 68 variant allele 68 CIN3 68 #ß 68 biochemical relapse 68 histological subtypes 68 mutated K ras 68 FluCAM arm 68 histologies 68 lactate dehydrogenase 68 leiomyoma 68 lichen planus 68 lymphocytosis 68 NSCLC tumors 68 cholangiocarcinoma 68 fluconazole resistant 68 HBeAg negative 68 monocytic 68 liver histology 68 colorectal carcinoma 68 GSTT1 68 neoplastic 68 tumor subtypes 68 advanced adenoma 68 acute leukemias 68 adenocarcinomas 68 TT genotype 68 galiximab 68 metastatic GIST 68 hepatoma 68 Prognostic factors 68 Multivariate analysis 68 prostate cancer PCa 68 urolithiasis 68 histologic 68 metastatic gastric 68 bladder carcinoma 68 intrahepatic 68 ERalpha 67 normal karyotype 67 metastatic prostate 67 neoplasm 67 nonmelanoma 67 thyrotropin 67 tryptase 67 Adenomas 67 BEXXAR Therapeutic Regimen 67 Diffuse Large B 67 renal pelvis 67 axillary lymph nodes 67 thymoma 67 locoregional recurrence 67 obstructive coronary artery 67 carcinoids 67 gastroduodenal 67 chromosomal mutations 67 etiologic 67 biochemical recurrence 67 ADPKD 67 leucopenia 67 nephrogenic 67 epithelioid 67 Subgroup analysis 67 lymphovascular invasion 67 ductal carcinomas 67 prognostic biomarker 67 LV dysfunction 67 troponin T 67 bronchial epithelial cells 67 TOP2A 67 bronchoalveolar lavage 67 stage IIIA 67 estrogen receptor ER 67 EGFR mutation status 67 varices 67 angiographically 67 Heritability 67 endothelial activation 67 histopathologic examination 67 atypical hyperplasia 67 precancerous cervical 67 posttransplant 67 postoperative complication 67 diabetes mellitus DM 67 lymphomas leukemias 67 HGPIN 67 carcinoid tumor 67 genotypic resistance 67 hepatic enzymes 67 interobserver reliability 67 EGFR mutation positive 67 pCR 67 percutaneous biopsy 67 inhibin 67 BRAF V#E 67 Doxil ® 67 endometrial carcinoma 67 pleural fluid 67 FDG PET imaging 67 myelodysplastic myeloproliferative diseases 67 intratumoral 67 ductal adenocarcinoma 67 Heavy menstrual bleeding 67 rFSH 67 Hematologic 67 advanced neoplasia 67 HLA DR4 67 histologically confirmed 67 astrocytomas 67 Soft Tissue Sarcoma 67 Chronic pancreatitis 67 IPAH 67 nodal metastases 67 idiopathic PAH 67 follicular thyroid cancer 67 Acute myeloid leukemia 67 elevated LDH 67 pretreatment serum 67 KRAS status 67 urine cytology 67 papillary carcinoma 67 gastrointestinal stromal tumors GISTs 67 Endometrial 67 radiochemotherapy 67 PCNSL 67 Metastases 67 mammographic density 67 intact parathyroid hormone 67 serum aminotransferase levels 67 metachronous 67 acute GvHD 67 thyroglobulin 67 Chronic lymphocytic leukemia 67 Chronic HCV 67 seropositivity 67 squamous histology 67 histopathologic 67 Legg Calvé Perthes disease 67 skeletal metastases 67 histopathological 67 recurrent glioblastoma multiforme 66 recurrent venous thromboembolism 66 prostate adenocarcinoma 66 nephrolithiasis 66 serum urate levels 66 SGPT 66 HSCT 66 Immunohistochemical staining 66 adenomatous polyps 66 cTnI 66 hepatic enzyme 66 cardiac troponin 66 axillary lymph node 66 alanine aminotransferase ALT 66 univariate analyzes 66 intestinal polyps 66 mesotheliomas 66 E. faecalis 66 T1a 66 SLNB 66 serous ovarian cancer 66 transabdominal 66 candidemia 66 vestibular schwannomas 66 PNH patients 66 malignant ascites 66 advanced adenomas 66 ovarian malignancy 66 Adjuvant therapy 66 cytoreductive surgery 66 % CI #.#-#.# [007] 66 papillary thyroid carcinoma 66 neuroendocrine carcinoma 66 leukemia AML 66 immunostaining 66 MTT assay 66 ertapenem 66 Estrogen Receptor 66 squamous 66 Elevated serum 66 chronic periodontitis 66 Waldenstrom macroglobulinemia 66 hematological parameters 66 Atherosclerotic 66 epithelial ovarian 66 pheochromocytomas 66 MALT lymphoma 66 lactate dehydrogenase LDH 66 splenic 66 Basal Cell 66 germline mutations 66 progesterone receptor PR 66 LVNC 66 antiangiogenic therapy 66 paraganglioma 66 hamartoma 66 System IPSS 66 μg liter 66 GSTP1 66 EGFR HER2 66 Polymorphisms 66 pancreatic carcinoma 66 metastatic pancreatic 66 seminoma 66 pilocytic astrocytomas 66 graft dysfunction 66 fibroma 66 serum homocysteine 66 artery stenosis 66 prognostic significance 66 hypercalciuria 66 MAGE A3 ASCI 66 KRAS mutation 66 leukocyte count 66 isoenzyme 66 thyroid nodules 66 peritoneal cancer 66 nondiabetic patients 66 preoperative diagnosis 66 pathologic diagnosis 66 #q# deletion 66 colorectal tumor 66 differential gene expression 66 mycosis fungoides 66 nonmalignant 66 lymphocytic leukemia 66 bullous 66 KRAS mutations 66 hypereosinophilic syndrome 66 deep venous thromboses 66 gemcitabine carboplatin 66 cutaneous melanoma 66 cytotoxicity assays 66 syngeneic 66 total thyroidectomy 66 hypermethylated 66 KRAS mutations occur 66 situ LCIS 66 histologically proven 66 thrombocytopenic 66 recurrent metastatic 66 oligodendrogliomas 66 hyperplastic 66 BRCA1 BRCA2 66 proximal colon 66 pleomorphic 66 hyperoxaluria 66 pancreatic prostate 66 bacteriuria 66 CSF biomarkers 66 gefitinib Iressa 66 multivariable adjusted 66 posttreatment 66 BRCA2 mutation carriers 66 adenomatous 66 lymph node metastases 66 liver transplant recipients 66 hepatocellular 66 Adenocarcinoma 66 B Cell Lymphoma 66 Adjuvant chemotherapy 66 logistic regression analysis 66 oncologic outcomes 66 trans retinoic acid 66 immunohistochemical analysis 66 Diabetic nephropathy 66 RRM1 66 serum prostate 66 BRCA deficient 66 heterozygotes 66 small lymphocytic lymphoma 66 thiopurine 66 IgA deficiency 66 CD4 CD8 66 gene polymorphisms 66 lobular carcinomas 66 renal tumors 66 hematologic toxicity 66 Venous thromboembolism 66 serum leptin 66 basal cell nevus syndrome 66 histologic findings 66 ABL1 66 underwent resection 66 International Prognostic Scoring 66 lymphocytic 66 immunohistochemical staining 66 hypercoagulable 66 lobular 66 thrombophilia 66 extracapsular extension 66 esophageal carcinoma 66 tertiles 66 ductal breast cancer 66 papillary 66 Index CDAI 66 leukocytosis 66 osteoid 66 serum lipid levels 66 liposomal amphotericin B 66 radiographic findings 66 lymphopenia 66 Tumor Response 66 calculi 66 recurrent UTI 66 visceral metastases 66 pancreatic endocrine 66 lung nodule 66 % CI #.#-#.# [003] 66 intravesical therapy 65 β blockers 65 Cardiotoxicity 65 HER2 receptor 65 cervical intraepithelial neoplasia 65 fulminant hepatic failure 65 transgene expression 65 uterine tumors 65 neurologic complications 65 resectable 65 HER2 amplification 65 antibody titer 65 TIMP 65 hemodynamically significant 65 ara C 65 glomerular filtration 65 TIMP 1 65 thromboembolic disease 65 unresectable tumors 65 nonalcoholic steatohepatitis 65 immunoreactivity 65 aminotransferases 65 aminotransferase 65 lymphoma subtypes 65 lung carcinomas 65 submucosal 65 endobronchial 65 microvessel density 65 myeloproliferative neoplasms 65 intestinal metaplasia 65 vWD 65 decompensated cirrhosis 65 intraoperative complications 65 cellularity 65 hyperparathyroidism 65 affective psychosis 65 leukocyte counts 65 serum selenium 65 de novo AML 65 CD# expression [002] 65 immunohistochemical 65 carotid plaques 65 bronchoalveolar 65 unfavorable cytogenetics 65 acute aortic dissection 65 mTOR inhibitors 65 Follicular Lymphoma 65 onset diabetes mellitus 65 thrombotic complications 65 von Willebrand 65 PTPN# 65 biliary tract cancer 65 transitional cell carcinoma 65 myocardial viability 65 GH deficiency 65 Hashimoto thyroiditis 65 urethral stricture 65 mononuclear 65 Vidaza azacitidine 65 C. trachomatis 65 Anaplastic 65 T#I [002] 65 pheochromocytoma 65 pain palliation 65 complement inhibitor eculizumab 65 anemia hemoglobin 65 pancreatic lung 65 rebleeding 65 intima media thickness 65 histopathologic diagnosis 65 peritumoral 65 PSA nadir 65 specific antigen PSA 65 Upregulation 65 polypoid 65 gene polymorphism 65 CP CPPS 65 tertile 65 carcinoid 65 neutrophil count 65 epithelial ovarian cancer 65 mutated KRAS 65 univariate analysis 65 surgically resectable 65 bile duct cancers 65 lymphoid malignancies 65 transfusion syndrome 65 elevated troponin 65 monogenic 65 C#BL 6 mice 65 mitochondrial toxicity 65 Hypertrophy 65 CLL SLL 65 Univariate analysis 65 adrenocortical 65 malignant cancerous 65 stage IIIB 65 bleomycin 65 pmol L 65 trastuzumab Herceptin ® 65 eccrine 65 serum concentrations 65 primary aldosteronism 65 eosinophil count 65 % CI #.#-#.# [008] 65 prostatic adenocarcinoma 65 ERK signaling 65 Hypotension 65 busulfan 65 colorectal neoplasms 65 autonomic dysfunction 65 micrometastasis 65 hematological relapse 65 stratifying patients 65 Sezary syndrome 65 cytogenetic abnormalities 65 invasive lobular 65 gadolinium enhanced 65 core needle biopsies 65 histopathologic findings 65 radiosensitivity 65 CD3 + 65 patients undergoing CABG 65 transcranial Doppler ultrasound 65 morphologic 65 aspartate aminotransferase AST 65 distal colon 65 Oropharyngeal 65 intracranial hemorrhage ICH 65 sonographic appearance 65 incidentalomas 65 ependymoma 65 endoscopic ultrasonography 65 neuritic 65 colorectal carcinomas 65 systemic amyloidosis 65 TMPRSS2 ERG fusion 65 plasma pharmacokinetics 65 metastatic lesion 65 chemoresistant 65 peritoneal carcinomatosis 65 Glioma 65 prospective multicenter study 65 lymph node involvement 65 antiproliferative effects 65 ductal cancer 65 hyper IgE syndrome 65 sonographically guided 65 arterial calcification 65 AST ALT 65 VKORC1 65 Pemetrexed 65 meningiomas 65 somatic mutation 65 abdominal adiposity 65 histologically 65 B7 H3 65 sonographically 65 gastrointestinal stromal tumor GIST 65 Ultrasonographic 65 duplex ultrasonography 65 Polycythemia vera 65 BRAF mutations 65 pituitary adenoma 65 induced sputum 65 preserved ejection fraction 65 interferon γ 65 LHRH agonists 65 SCr 65 nonsmall cell lung cancer 65 intestinal permeability 65 neoplasia 65 susceptibility loci 65 differentially expressed genes 65 nonalcoholic steatohepatitis NASH 65 Lymph node 65 neoadjuvant treatment 65 metastatic malignant melanoma 65 myeloperoxidase 65 Common Toxicity Criteria 65 Surgical resection 65 pharmacodynamic parameters 65 atypical hemolytic uremic syndrome 65 Mitomycin C 65 polyp recurrence 65 malignant pleural mesothelioma MPM 65 esophageal squamous cell carcinoma 65 neoadjuvant therapy 65 BRCA mutation carriers 65 myelofibrosis polycythemia vera 65 lobular carcinoma 65 tumor xenograft models 65 hematologic parameters 65 hydronephrosis 65 renal biopsy 65 T2DM 65 HBeAg 65 troponins 65 malignant fibrous histiocytoma 65 chemosensitivity 65 carcinoembryonic antigen 65 Mutational 65 murine models 65 nonischemic 65 HCV replicon 65 p# biomarker 65 nasopharyngeal carcinoma 65 serum cortisol 65 Febrile neutropenia 65 non squamous NSCLC 65 breast endometrial 65 Fas ligand 65 serum lactate 65 adnexal mass 65 haematopoietic 65 tumors GIST 65 cTnT 65 MSH2 65 #F FDG PET 65 Histologically 64 HER2 positivity 64 Myelodysplastic syndromes MDS 64 electrophysiologic 64 Renal dysfunction 64 perioperative morbidity 64 homozygotes 64 Hepatocellular Carcinoma HCC 64 lymphoid cells 64 Nonspecific 64 fetal malformations 64 cisplatin gemcitabine 64 differentiated thyroid 64 symptomatic VTE 64 intraobserver 64 nonproliferative 64 ErbB2 positive 64 renal scarring 64 poor metabolizers 64 EGFR mutant 64 ECOG PS 64 melanocytic nevi 64 intrathoracic 64 Endometrial cancer 64 intracerebral 64 BCR ABL mutations 64 kidney allograft 64 Akt activation 64 Genetic variation 64 PsA 64 KRAS oncogene 64 bronchoalveolar lavage fluid 64 lymphadenectomy 64 rs# [004] 64 transthyretin amyloidosis 64 glomerular 64 hyperalgesia 64 hypervascular 64 hepato 64 lymphangiogenesis 64 MGd 64 PHPT 64 oesophageal adenocarcinoma 64 pancreatic fistula 64 debulking surgery 64 etiologic agent 64 idiopathic pulmonary 64 basal cell skin 64 steroidogenesis 64 bacterial prostatitis 64 -#.# ± [002] 64 MLH1 64 serum calcium levels 64 Genotypes 64 neurocognitive function 64 BRAF V#E mutation 64 haematological 64 Non Alcoholic Fatty 64 Non Alcoholic Steatohepatitis 64 FDG-PET/CT 64 intra abdominal abscess 64 Severe Primary IGFD 64 Atypical Hemolytic Uremic Syndrome 64 intraventricular 64 HLA DRB1 * 64 aminotransferase levels 64 esophagogastric junction 64 bronchioloalveolar carcinoma 64 hepatic cirrhosis 64 carcinoma HCC 64 pediatric acute lymphoblastic 64 parous women 64 smoldering myeloma 64 Stomatitis 64 transrectal ultrasound guided 64 QTc prolongation 64 fallopian tube cancers 64 adjuvant systemic 64 macroalbuminuria 64 peritoneal fluid 64 PAOD 64 malignant neoplasms 64 inducible nitric oxide synthase 64 F FDG uptake 64 transaminase elevations 64 isoprostane 64 fallopian tube carcinoma 64 serum PSA 64 BMPR2 64 HER2 positive cancers 64 rFVIIa 64 pulmonary nodules 64 POAG 64 periventricular 64 catheter angiography 64 noncardiac 64 breast cancer metastasis 64 extracranial 64 haematopoietic stem cell 64 precancerous condition 64 parathyroid carcinoma 64 azacytidine 64 interobserver 64 elevated transaminases 64 alanine aminotransferase 64 imatinib Gleevec 64 creatine kinase MB 64 urinary N telopeptide 64 nutlin 3a 64 Glioblastoma multiforme GBM 64 hemodialysis patients 64 malignant lymphoma 64 Candida infection 64 osteoblastic 64 untreated celiac disease 64 hA# 64 LPS induced 64 confidence intervals CIs 64 HRCT 64 Multiple Myeloma MM 64 inflammatory biomarkers 64 NAbs 64 hormone receptor negative 64 benign nodules 64 HBV genotype 64 RAS mutations 64 antidiabetic medication 64 cytopenias 64 lymphocyte count 64 Toxicities 64 neointimal 64 proctitis 64 genomic alterations 64 colorectal liver metastases 64 follicular lymphoma FL 64 Preoperative 64 GnRH agonist 64 invasive ductal breast cancer 64 intraventricular hemorrhage 64 VEGF expression 64 cytoreductive nephrectomy 64 severe hypersensitivity reactions 64 premalignant 64 underwent surgical resection 64 hyperintensity 64 paraneoplastic 64 univariate 64 ANCA associated 64 5alpha reductase 64 steatohepatitis 64 Radiofrequency ablation 64 multivariate regression analysis 64 prospectively defined 64 ductal 64 palliative radiotherapy 64 tumor subtype 64 lobular breast cancer 64 postoperative delirium 64 adenoma recurrence 64 xenograft tumors 64 Multivariate logistic regression 64 thyrotoxicosis 64 hypocalcaemia 64 Genetic variants 64 Wegener granulomatosis 64 postoperative AF 64 radiotherapy RT 64 tonsillar 64 urothelial bladder cancer 64 Poisson regression 64 molecular abnormalities 64 pretest probability 64 Leydig cells 64 cancer mCRC 64 ductal lobular 64 immunocompetent 64 hyperacute 64 lesional 64 IL6 64 prognostic indicator 64 airway hyperresponsiveness 64 gonococcal infections 64 Aortic stenosis 64 Medullary thyroid cancer 64 abacavir Ziagen 64 neurocognitive impairment 64 osteoclastic 64 elevated IOP 64 renal tubular 64 localized prostate 64 interleukin IL -# 64 Breslow thickness 64 benign noncancerous 64 Retreatment 64 CD4 + CD# 64 histologic examination 64 Myelosuppression 64 polycythemia vera PV 64 thromboembolic complications 64 FGFR2 gene 64 prostate carcinomas 64 CYT# potent vascular disrupting 64 hepatocellular carcinoma liver 64 postoperative morbidity 64 multiple logistic regression 64 Nilotinib 64 Vidaza ® 64 perioperative complications 64 EGF receptors 64 pelvic lymphadenectomy 64 mesangial 64 seminal vesicle invasion 64 interstitial fibrosis 64 ultrasonographic 64 Comorbidity 64 inhibin B 64 acute lymphoblastic 64 CYP #D# 64 P. acnes 64 Inhibin B 64 prospectively stratified 64 CC genotype 64 TMPRSS2 ERG 64 Leukine ® 64 acromegalic patients 64 cell acute lymphoblastic 64 HNPCC 64 abnormal cytology 64 prognostic markers 64 pleurodesis 64 invasive aspergillosis 64 sinonasal 64 plasma folate 64 malignant lesions 64 Cytogenetic 64 portal vein thrombosis 64 albumin excretion rate 64 UGT#A# * 64 malignant prostate 64 Hematopoietic 64 distant metastases 64 renal allograft 64 BCL#A 64 postoperative mortality 64 cytological 64 tamoxifen Nolvadex ® 64 erythema nodosum 64 BRCA1 mutation carriers 64 retrospective cohort 64 Hypertrophic 64 Glioblastoma Multiforme 64 subtrochanteric 64 acetabular fractures 64 Familial Hypercholesterolemia 64 logistic regression analyzes 64 eosinophilia 64 vaginal lesions 64 gene rearrangements 64 morphometric vertebral fractures 64 missense mutations 64 myelomas 64 Lp PLA 2 64 nonvertebral fracture 64 genetic polymorphisms 64 chorioamnionitis 64 cytogenic 64 prognostic factors 64 receptor subtypes 64 corticosteroid induced 64 chronic prostatitis 64 KRAS mutation status 64 seminal vesicle 64 JAK2 V#F 64 cardiac troponin T 64 Flu Cy 64 p# biomarkers 64 Proteinuria 64 cytomegalovirus infection 64 hypophosphatemia 64 systolic dysfunction 64 hypothalamic pituitary 64 thalidomide Thalomid 64 resectable pancreatic cancer 64 circadian genes 63 androgen ablation 63 vesicoureteral reflux 63 malignant pleural mesothelioma 63 wedge resection 63 GLIADEL R Wafer 63 myeloproliferative 63 antiangiogenic agent 63 demyelinating 63 torsade de pointes 63 immunopathology 63 cerebral infarction 63 oropharyngeal 63 ^ sup #m 63 pulmonary alveolar 63 thickness IMT 63 postoperative pulmonary 63 tissue oxygenation 63 steroidogenic 63 chromosome #p#.# 63 vWF 63 BALF 63 tipranavir ritonavir 63 concomitant medications 63 chromosomal aberrations 63 HOMA IR 63 cytokeratin 63 #OHD 63 leukoencephalopathy 63 â ‰ ¥ 63 KRAS wild 63 lumbar disk herniation 63 tumor necrosis 63 Kaplan Meier analysis 63 situ CIS 63 perioperatively 63 familial aggregation 63 polycythemia vera essential thrombocythemia 63 Kaplan Meier 63 malignant ovarian 63 vincristine doxorubicin 63 serum ferritin 63 serum creatinine levels 63 CLINICAL PHARMACOLOGY 63 recurrent VTE 63 metabolomic profiles 63 ALT flares 63 atrophic gastritis 63 neutrophil counts 63 #F FDG